FDA gives green light to remote monitoring in clinical trial

The agency also approves a drug company’s techniques aimed at getting more physician and patient input through the use of online tools.

By — Posted Jan. 9, 2013

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Federal Drug Administration has approved a clinical drug trial that is unique for two reasons. It used crowdsourcing, including physicians, for the design of the trial. And it’s using telemonitoring to track patient data.

The FDA granted new drug status to a proposal by drug development company Transparency Life Sciences to conduct a phase II study of the effect of a widely used hypertension drug, lisinopril, in patients with multiple sclerosis. The trial was designed using feedback from an online crowdsourcing system, the first clinical drug trial of its kind to use crowdsourcing in its design.

“What we aim to do is get physicians involved with the design of these trials more systematically,” said Marc Foster, co-founder and chief operating officer of TLS. The company wants a broader set of ideas when it comes to clinical trial design. It is opening up the process through an online system where both physicians and patients can submit ideas.

The company will use telemonitoring to collect patient data rather than requiring patients to see clinical trial personnel. Telemonitoring not only will reduce the number of in-person visits to two, but it also will bring the cost of the clinical trial down to an estimated $1.5 million, compared with the $5 million to $10 million that a phase II study typically costs.

“When we speak with patients, and when patients are involved in conversations about clinical trials, time and time again they talk about the inconvenience of having to take off chunks of the day to go in and have data collected in a hospital or clinic setting,” Foster said. “And with telemonitoring we can put a lot of this data collection into patients’ homes, so we very much anticipate this will be an incentive for more patients to participate in clinical trials.”

The company partnered with AMC Health, a developer of telehealth technology, for the trial. John Holland, senior vice president for research and business development for AMC, said there is increasing recognition that the high price of clinical trials keeps companies from taking new medications to market.

He said a shift in FDA policy also has opened the door for telemonitoring to be used. More than a year ago it changed its policy of requiring 100% verification of every data point as a way of detecting fraud. It has developed other ways of looking for fraud, he said.

Back to top



Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story

Read story


American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story

Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story

Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story

Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story

Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story

Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story

Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn